Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adaptimmune Ther Ads (NQ: ADAP )

5.720 USD -0.380 (-6.23%)
Streaming Delayed Price Updated: 4:01 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Adaptimmune Ther Ads

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
First Week of ADAP February 19th Options Trading
Investors in Adaptimmune Therapeutics PLC (ADAP) saw new options become available this week, for the February 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down... 
Tags Stocks
From Market News Video
5 Best Penny Stocks To Buy Now According To Insiders
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
First Week of January 2021 Options Trading For Adaptimmune Therapeutics (ADAP)
Investors in Adaptimmune Therapeutics PLC (ADAP) saw new options become available this week, for the January 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
Adaptimmune to Showcase Market Potential for SPEAR T-cell Portfolio and Pipeline with Multiple Cell Therapy Platforms During Virtual Investor Day
From GlobeNewswire News Releases
Durable Responses with ADP-A2M4 in Synovial Sarcoma with Confirmed Responses in 44% of Patients and Disease Control Rate of 94% Presented at CTOS
From GlobeNewswire News Releases
Adaptimmune to Host Virtual Investor Day on Friday, November 20th
From GlobeNewswire News Releases
Two Confirmed Responses and Five out of Six Patients with Initial Tumor Reductions from Early Dose Cohorts of SURPASS Trial, Presented at SITC
From GlobeNewswire News Releases
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags MRKR SNY OPNT
From Benzinga
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags NBRV BMY MYOK
From Benzinga
Adaptimmune Reports Q3 Financial Results and Business Update
From GlobeNewswire News Releases
54 Biggest Movers From Yesterday
Gainers Endurance International Group Holdings, Inc. (NASDAQ: EIGI) shares jumped 62% to close at $9.41 on Monday after the ... 
Tags VHC MRIN MICT
From Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ... 
Tags MNKD RDUS CLVS
From Benzinga
50 Biggest Movers From Friday
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 62.7% to close at $3.45 on Friday, reversing from ... 
Tags NKTX DPHC KBSF
From Benzinga
Stock watchlist for the coming trading week
Tags GNUS AESE GLBS
From AC Investor Blog
12 Healthcare Stocks Moving In Friday's Intraday Session
Gainers Adaptimmune Therapeutics (NASDAQ:ADAP) stock moved upwards by 13.95% to $4.9 during Friday's regular session. As of 12:31 ... 
Tags KYMR Health Care CASI
From Benzinga
Adaptimmune to Report Q3 Financial Results and Business Update on Thursday, November 5, 2020
From GlobeNewswire News Releases
60 Biggest Movers From Yesterday
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares jumped 150.7% to close at $3.76 on Wednesday following a 22% surge on ... 
Tags GSX SELB MRIN
From Benzinga
Adaptimmune Therapeutics is Now Oversold (ADAP)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
64 Biggest Movers From Friday
Gainers Hertz Global Holdings (NYSE: HTZ) stock climbed 142.7% to close at $2.50 on Friday following news the company secured ... 
Tags ORTX Movers LAZY
From Benzinga
Notable Two Hundred Day Moving Average Cross - ADAP
In trading on Friday, shares of Adaptimmune Therapeutics PLC (ADAP) crossed below their 200 day moving average of $6.26, changing hands as low as $6.25 per share. Adaptimmune Therapeutics PLC shares... 
Tags Stocks
From Market News Video
Why Adaptimmune's Stock Is Trading Lower Today
Adaptimmune Therapeutics (NASDAQ: ADAP) are trading lower on Friday. The company late Thursday provided the full contents of its SITC ... 
Tags General Benzinga why it's moving
From Benzinga
12 Healthcare Stocks Moving In Friday's Intraday Session
Gainers ReWalk Robotics (NASDAQ:RWLK) stock rose 16.37% to $1.35 during Friday's regular session. As of 12:31 EST, this ... 
Tags BMRA GRTX Movers
From Benzinga
50 Stocks Moving In Friday's Mid-Day Session
Gainers Hertz Global Holdings (NYSE: HTZ) stock jumped 95.1% to $2.0098 following news the company secured $1.65 billion in ... 
Tags NAV Intraday Update NAKD
From Benzinga
Adaptimmune Provides Full Contents of its SITC Abstract for the Phase 1 SURPASS Trial
From GlobeNewswire News Releases
54 Biggest Movers From Yesterday
Gainers Medalist Diversified REIT, Inc. (NASDAQ: MDRR) shares climbed 147.8% to close at $2.85 on Wednesday. Medalist Diversified ... 
Tags GME REPL Top Gainers
From Benzinga
Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation
From InvestorBrandNetwork
Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation
NetworkNewsWire Editorial Coverage 
From PR Newswire
80 Biggest Movers From Yesterday
Gainers Cassava Sciences, Inc. (NASDAQ: SAVA) shares surged 133.4% to close at $7.75 on Monday after the company announced ... 
Tags INFY IBEX GILD
From Benzinga
60 Stocks Moving In Monday's Mid-Day Session
Gainers Immunomedics, Inc. (NASDAQ: IMMU) shares climbed 100.6% to $84.74. Gilead Sciences, Inc. (NASDAQ: GILD) announced plans to ... 
Tags KC Market News ENLV
From Benzinga
Promising Data from Phase 1 Trial with ADP-A2AFP in Liver Cancer at the International Liver Congress Confirm Safety Profile and Demonstrate Potential Benefit for Patients
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.